Heart drug showdown: new combo pill vs old standard in kids

This study compares two heart failure medications—sacubitril/valsartan (a newer combo drug) and captopril (an older drug)—in 70 children aged 1 month to 18 years with dilated cardiomyopathy (an enlarged, weak heart). The goal is to see which drug better improves the heart's pumping ability over 12 months. Children must be stable on other heart therapies before joining, and those with severe kidney problems or allergies to the drugs cannot participate.